In Swiss nu/nu mice with implanted human TC-118 cancer cells, simultaneous administration of 5-fluorouracyl and GNL resulted in 53% tumor volume reduction, versus 26% for GNL alone and no difference for 5-fluorouracyl alone [15]. The gene discussed is RGN; the disease is cancer.